Stockscreener 앱 받기
5.1885
0.29%
-0.0115
Compass Pathways Plc Adr 주식(CMPS)의 최신 뉴스
Investors in cash trouble should check out Compass Pathways Plc ADR (CMPS) - Setenews
Bridger Management LLC Purchases New Holdings in COMPASS Pathways PLC Sponsored ADR $CMPS - Defense World
The time has not yet come to remove your chips from the table: Compass Pathways Plc ADR (CMPS) - Setenews
Free cash flow per share of COMPASS Pathways Plc Sponsored ADR – LS:A2QCDR - TradingView
COMPASS Pathways (NASDAQ:CMPS) Shares Gap UpTime to Buy? - MarketBeat
This trade activity should not be overlooked: Compass Pathways Plc ADR (CMPS) - Setenews
Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months - Placera.se
Sumitomo Mitsui Trust Group Inc. Has $615,000 Stock Holdings in COMPASS Pathways PLC Sponsored ADR $CMPS - Defense World
NeuroKaire Enters into R&D Collaboration with Compass Pathways to Pioneer Precision Treatments for Depression - Barchart.com
Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors - ANSA
Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025 - Barchart.com
ARK Investment Management LLC Sells 155,582 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
Compass Pathways soars 62% after December Fair Value signal - Investing.com
Compass Pathways: Maintain Hold Rating With COMP360 Going Beyond TRD Development (CMPS) - Seeking Alpha
COMPASS Pathways (NASDAQ:CMPS) Reaches New 52-Week High After Analyst Upgrade - Defense World
COMPASS Pathways (NASDAQ:CMPS) Price Target Raised to $14.00 at BTIG Research - Defense World
COMPASS Pathways (NASDAQ:CMPS) Sets New 52-Week High After Analyst Upgrade - MarketBeat
COMPASS Pathways (NASDAQ:CMPS) Sets New 12-Month HighWhat's Next? - MarketBeat
Goldman Sachs Group Inc. Sells 81,540 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
COMPASS Pathways (NASDAQ:CMPS) Trading 6.4% HigherShould You Buy? - MarketBeat
Brokerages Set COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) PT at $16.29 - MarketBeat
Woodline Partners LP Purchases 1,292,927 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
Polar Asset Management Partners Inc. Acquires Shares of 229,806 COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
Vident Advisory LLC Invests $95,000 in COMPASS Pathways PLC Sponsored ADR $CMPS - Defense World
Driehaus Capital Management LLC Invests $2.01 Million in COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
Nantahala Capital Management LLC Purchases 1,829,232 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
DAFNA Capital Management LLC Raises Holdings in COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives $16.29 Consensus Target Price from Analysts - Defense World
22NW LP Acquires New Position in COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
CMPS Stock Price and Chart — NASDAQ:CMPS - TradingView
HC Wainwright Issues Negative Outlook for CMPS Earnings - Defense World
Analysts Set COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Price Target at $17.00 - Defense World
Compass (CMPS) Q2 Loss Improves 27% - The Globe and Mail
Can Compass Pathways Plc ADR Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com
Compass Pathways appoints former GW Pharmaceuticals CEO to board - Investing.com India
Compass Pathways appoints former GW Pharmaceuticals CEO to board By Investing.com - Investing.com South Africa
HC Wainwright Lowers Earnings Estimates for COMPASS Pathways - Defense World
Equities Analysts Issue Forecasts for CMPS Q1 Earnings - Defense World
CMPS: Riding the Market Waves of Growth and Decline in 2025 - investchronicle.com
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives $17.00 Average Target Price from Brokerages - Defense World
WPP (LON:WPP) Stock Price Down 18.8% Following Analyst Downgrade - Defense World
Helen of Troy (NASDAQ:HELE) Hits New 1-Year Low After Earnings Miss - Defense World
Promising Chinese Stocks To Research – July 9th - Defense World
Epiroc AB (publ) (EPOKY) Projected to Post Earnings on Friday - Defense World
COMPASS Pathways (CMPS) Upgraded to Buy: Here's Why - MSN
This Psychedelic Drug Flopped on Trial Results. Should You Buy the Dip? - Barchart.com
Compass’ stock slips despite psilocybin trial hitting target - Clinical Trials Arena
Compass Pathways reports positive Phase 3 trial results for COMP360 in depression - Investing.com
Compass Pathways Holds Annual General Meeting By Investing.com - Investing.com South Africa
Compass Pathways Holds Annual General Meeting - Investing.com
COMPASS Pathways (CMPS) Upgraded to Buy: Here's What You Should Know - Nasdaq
Compass Pathways appoints new US accounting firm - Investing.com
0.72%
자본화:
|
볼륨(24시간):